It was a blockbuster trade in the NBA. The Cleveland Cavaliers sent point guard Kyrie Irving to the Boston Celtics for players Isaiah Thomas, Jae Crowder, Ante Zizic and the Brooklyn Nets’ 2018 first-round pick. By most accounts, it was a great haul for the Cavs who got and more than fair value for a player that was looking to leave Cleveland and get out of the shadow of Lebron Games.
Unfortunately, after a physical conducted by the Cavs organization, it appears that one of the players involved in the deal—Isaiah Thomas—isn't 100% healthy. Hip problems have the Cavs concerned and since Thomas was the central piece of the trade coming back to Cleveland, so things aren't sitting well with a Cavs organization who might be looking for additional components to complete the trade, according to ESPN.
When it comes to revising the trade, it is possible the Celtics say no. The belief from the Boston perspective is that they were completely transparent about the severity of Thomas' injuries and where he was at with his rehab. The organization feels they made it clear that Thomas has been rehabilitating a hip injury that ended his 2016-17 season in the Eastern Conference finals, and he has yet to begin a regimen of running this offseason. He's potentially going to miss significant time to start this coming NBA campaign.
Because they informed the Cavs of this news, they'll be resisting the idea of adding another piece to finish this trade. If that happens, the Cleveland Cavaliers have the power to veto the deal altogether.
Why would they do so? Because Thomas is in the final year of his contract as is the Cavs superstar LeBron James. The Cavaliers believe that in order to compete with a team like the Golden State Warriors, both players need to be on the court at the same time. If James chooses to opt-out of his contract next summer, Cleveland has a player moving forward in Thomas who is not nearly as effective without James as he would be with him.
Cleveland is in win-now mode. They may only have one season left with James, and if that's the case, they need a significant return for a player like Kyrie Irving. A healthy Thomas would have helped, but if he can't play, the trade value isn't there. The next couple days will speak loudly in terms of where this deal sits.